Top Authors

• Most frequent coverage on MNTA

• 
  Mike Havrilla (1946 followers)

  • Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely (Wed, Oct 7)
  • Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk (Wed, Sep 23)
  • BioMed News Bytes: Arena, Momenta, Vivus (Sun, Sep 20)

  More by Mike Havrilla on MNTA »
• 
  Bespoke Investment Group (3555 followers)

  • Best and Worst Performing Stocks Seven Months Into 2008 (Mon, Aug 4)
  • Another Month of '08 in the Books (Thu, May 1)
  • Q1's Best and Worst Performing Stocks (Tue, Apr 1)

  More by Bespoke Investment Group on MNTA »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Day In Review: Sanofi Loses Lovenox Patent (Sun, Feb 11)

  More by Centient Biotech Investor on MNTA »

• Most followed authors on MNTA

• 
  Bespoke Investment Group (3555 followers)

  • Best and Worst Performing Stocks Seven Months Into 2008 (Mon, Aug 4)
  • Another Month of '08 in the Books (Thu, May 1)
  • Q1's Best and Worst Performing Stocks (Tue, Apr 1)

  More by Bespoke Investment Group on MNTA »
• 
  Mike Havrilla (1946 followers)

  • Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely (Wed, Oct 7)
  • Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk (Wed, Sep 23)
  • BioMed News Bytes: Arena, Momenta, Vivus (Sun, Sep 20)

  More by Mike Havrilla on MNTA »
• 
  Marco Hickey (1317 followers)

  • 30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch (Sun, Jun 28)

  More by Marco Hickey on MNTA »

• Newest authors on MNTA

• 
  M. E. Garza (522 followers)

  • Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS (Sun, Jun 28)

  More by M. E. Garza on MNTA »
• 
  The Burrill Report (207 followers)

  • Sanofi Pulls the Plug on Two Drugs: Biotech's Latest Mishaps (Thu, Dec 24)

  More by The Burrill Report on MNTA »
• 
  Marco Hickey (1317 followers)

  • 30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch (Sun, Jun 28)

  More by Marco Hickey on MNTA »

• Most commented on MNTA

• 
  Mike Havrilla (1946 followers)

  • Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely (Wed, Oct 7)
  • Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk (Wed, Sep 23)
  • BioMed News Bytes: Arena, Momenta, Vivus (Sun, Sep 20)

  More by Mike Havrilla on MNTA »
• 
  M. E. Garza (522 followers)

  • Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS (Sun, Jun 28)

  More by M. E. Garza on MNTA »
• 
  Bespoke Investment Group (3555 followers)

  • Best and Worst Performing Stocks Seven Months Into 2008 (Mon, Aug 4)
  • Another Month of '08 in the Books (Thu, May 1)
  • Q1's Best and Worst Performing Stocks (Tue, Apr 1)

  More by Bespoke Investment Group on MNTA »